Response to “Women’s Knowledge of Genomic Testing and Precision Medicine in Breast Cancer Treatment Decision-Making”
Oncology Nursing Forum · 2024
DOI: 10.1188/24.onf.422-424 ↗Kurz gefasst
Leserbrief in der Zeitschrift Oncology Nursing Forum, 2024. Verfasst von Suzanne M Mahon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Saint Louis University. Hauptthemen laut MEDLINE: Breast Neoplasms, Precision Medicine, Genetic Testing, Decision Making.
Abstract (Originalsprache)
We would like to thank authors Robles-Rodriguez et al. (2024) for their recent article on patient perceptions and knowledge of genomic science in the treatment of breast cancer. The authors appropriately note that physicians may lack knowledge about genomic science, as it is not covered extensively in medical training. The same is true of nursing education (Thomas et al., 2023).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Saint Louis University.
- Loyola University Chicago.
- Oncology Outreach Programs, Cooper University Hospital, Camden, NJ.
Zitieren
APA
Mahon, S. M., Friend, P., & Robles-Rodriguez, E. (2024). Response to “Women’s Knowledge of Genomic Testing and Precision Medicine in Breast Cancer Treatment Decision-Making”. Oncology Nursing Forum. https://doi.org/10.1188/24.onf.422-424
Vancouver
Mahon SM, Friend P, Robles-Rodriguez E. Response to “Women’s Knowledge of Genomic Testing and Precision Medicine in Breast Cancer Treatment Decision-Making”. Oncology Nursing Forum. 2024. doi:10.1188/24.onf.422-424
BibTeX
@article{Mahon2024,
author = {Mahon, Suzanne M and Friend, Patricia and Robles-Rodriguez, Evelyn},
title = {Response to “Women’s Knowledge of Genomic Testing and Precision Medicine in Breast Cancer Treatment Decision-Making”},
journal = {Oncology Nursing Forum},
year = {2024},
doi = {10.1188/24.onf.422-424}
}
EUVIMED